Listening to the elephant in the room: response-shift effects in clinical trials research

Response shift https://t.co/MSNhfnQcOZ

RT @IChanHuang1: In 2022 ISOQOL Annual Conference, Carolyn notifies response-shift effects on patient-reported outcomes assessed in clinica…

In 2022 ISOQOL Annual Conference, Carolyn notifies response-shift effects on patient-reported outcomes assessed in clinical trials DO exist. Also, see our paper in J Patient Rep Outcomes 2022. https://t.co/a42msXziXj @IChanHuang1 #ISOQOL2022 #ResponseShif

RT @jrboehnke: Carolyn Schwartz presents on the relevance of #ResponseShift in clinical trials https://t.co/qjsEMBKXnK And if you are wond…

Carolyn Schwartz presents on the relevance of #ResponseShift in clinical trials https://t.co/qjsEMBKXnK And if you are wondering: no, it is not measurement bias, but information, as argued by the group of researchers here: https://t.co/lEu65HBuL2 #ISOQOL

RT @jrboehnke: Scoping review (17papers/4 #RCT) suggests #ResponseShift effects overlay treatment effects: https://t.co/Bsezp0OAjn The cal…

Scoping review (17papers/4 #RCT) suggests #ResponseShift effects overlay treatment effects: https://t.co/Bsezp0OAjn The call for the formal consideration of RS effects in #RCT-s was also highlighted as a research priority here 👉https://t.co/iXTfBLn7GT #H

Listening to the elephant in the room: response-shift effects in clinical trials research https://t.co/tXTfYmwHNT